109 related articles for article (PubMed ID: 1846280)
21. [A case of verrucous carcinoma showing a good partial response by C.P.E. (CDDP, PEP, etoposide) chemotherapy].
Yamamoto G; Oshitani T; Shiraishi T; Takigami K; Kitamura K; Sawatari S; Mori M; Yamaguchi Y; Hyo Y; Yoshitake K
Gan To Kagaku Ryoho; 1992 Jan; 19(1):111-3. PubMed ID: 1370366
[TBL] [Abstract][Full Text] [Related]
22. [Prolonged oral etoposide therapy in advanced stage lung cancer].
Bozóky G; Ruby E; Góhér I; Mohos A; Lengyel M
Orv Hetil; 1997 Jul; 138(28):1791-5. PubMed ID: 9280873
[TBL] [Abstract][Full Text] [Related]
23. [Combined chemotherapy after prolonged oral etoposide maintenance therapy in patients with small-cell lung cancer].
Bozóky G; Ruby E; Góhér I; Mohos A
Orv Hetil; 2000 Sep; 141(37):2035-8. PubMed ID: 11037613
[TBL] [Abstract][Full Text] [Related]
24. Chronic oral etoposide: trials at Indiana University and with the Hoosier Oncology Group.
Loehrer PJ
Semin Oncol; 1992 Dec; 19(6 Suppl 14):48-52. PubMed ID: 1336900
[TBL] [Abstract][Full Text] [Related]
25. [A case of small cell carcinoma of the lung responding well to oral etoposide therapy].
Nakaoka Y; Haraguchi M; Fujii T; Adachi N; Komatsu T; Ota K; Kurihara N
Gan To Kagaku Ryoho; 1991 Apr; 18(4):637-9. PubMed ID: 1849393
[TBL] [Abstract][Full Text] [Related]
26. Carboplatin plus oral etoposide in elderly patients with advanced non small cell lung cancer. A phase II study.
Gridelli C; Rossi A; Scognamiglio F; Guida C; Fiore F; Gatani T; Scoppa G; Pergola M
Anticancer Res; 1997; 17(6D):4755-8. PubMed ID: 9494602
[TBL] [Abstract][Full Text] [Related]
27. Pharmacology of 21-day oral etoposide given in combination with i.v. cisplatin in patients with extensive-stage small cell lung cancer: a cancer and leukemia group B study (CALGB 9062).
Miller AA; Rosner GL; Ratain MJ; Hollis DR; Green MR; Schilsky RL
Clin Cancer Res; 1997 May; 3(5):719-25. PubMed ID: 9815741
[TBL] [Abstract][Full Text] [Related]
28. [A phase II study of etoposide (VP-16) injection in primary lung cancer by cooperative study group].
Kado M; Oshima S; Matsui Y; Shimokata K; Hara K; Kanda T; Shima K; Takenaka S
Gan To Kagaku Ryoho; 1986 Jan; 13(1):116-21. PubMed ID: 3002282
[TBL] [Abstract][Full Text] [Related]
29. [Clinical study of etoposide (NK 171s, miniaturized capsule) in advanced small cell lung cancer].
Niitani H; Hasegawa K; Takizawa H; Nakano H; Yoshida S; Uchiyama T; Matsuoka T; Nagao K; Komatsu H; Sato H
Gan To Kagaku Ryoho; 1992 Apr; 19(4):561-4. PubMed ID: 1313669
[No Abstract] [Full Text] [Related]
30. Etoposide/vincristine-based chemotherapy with or without carboplatin in extensive-stage small cell lung cancer: a prospective randomized phase III trial.
Gatzemeier U; Pawel JV; Laumen R; Hossfeld DK; Neuhauss R
Semin Oncol; 1994 Jun; 21(3 Suppl 6):31-5. PubMed ID: 8052871
[TBL] [Abstract][Full Text] [Related]
31. [Nedaplatin and etoposide combination chemotherapy in a patient with small cell carcinoma undergoing hemodialysis].
Nishioka Y; Kitada O; Meguro T; Aragane K; Tanimukai T; Nakamura H; Nakahama H; Matsuyama T; Sugita M; Yano T; Takenaka Y; Takamitsu Y
Gan To Kagaku Ryoho; 1999 Mar; 26(4):527-30. PubMed ID: 10097751
[TBL] [Abstract][Full Text] [Related]
32. A phase I trial of carboplatin and etoposide for elderly (>or=75 year-old) patients with small-cell lung cancer.
Fukuda M; Soda H; Soejima Y; Fukuda M; Kinoshita A; Takatani H; Kasai T; Nagashima S; Kawabata S; Doi S; Kohno S; Oka M
Cancer Chemother Pharmacol; 2006 Nov; 58(5):601-6. PubMed ID: 16463061
[TBL] [Abstract][Full Text] [Related]
33. [Combination chemotherapy with carboplatin and etoposide for elderly patients aged 76 years or older with small cell lung cancer].
Tada A; Ueoka H; Kiura K; Tabata M; Takemoto M; Yamane H; Hiyama J; Aoe K; Shibayama T; Kamei H; Kawahara S; Harita S; Sato T; Kobayashi M; Eguchi K; Hiraki S; Hiraki Y; Tanimoto M
Gan To Kagaku Ryoho; 2002 May; 29(5):751-6. PubMed ID: 12040679
[TBL] [Abstract][Full Text] [Related]
34. [Etoposide-induced pneumonitis].
Hatakeyama S; Tachibana A; Morita M; Suzuki K; Okano H
Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Feb; 35(2):210-4. PubMed ID: 9103861
[TBL] [Abstract][Full Text] [Related]
35. Oral etoposide and carboplatin. Effective therapy for elderly patients with small cell lung cancer.
Evans WK; Radwi A; Tomiak E; Logan DM; Martins H; Stewart DJ; Goss G; Maroun JA; Dahrouge S
Am J Clin Oncol; 1995 Apr; 18(2):149-55. PubMed ID: 7534977
[TBL] [Abstract][Full Text] [Related]
36. A phase I study of paclitaxel, etoposide, and cisplatin in extensive stage small cell lung cancer.
Kelly K; Pan Z; Wood ME; Murphy J; Bunn PA
Clin Cancer Res; 1999 Nov; 5(11):3419-24. PubMed ID: 10589753
[TBL] [Abstract][Full Text] [Related]
37. Paclitaxel, carboplatin, and extended schedule etoposide in the treatment of small cell lung carcinoma.
Hainsworth JD; Stroup SL; Greco FA
Cancer; 1996 Jun; 77(12):2458-63. PubMed ID: 8640693
[TBL] [Abstract][Full Text] [Related]
38. Open-label, multicenter, randomized, phase III study comparing oral topotecan/cisplatin versus etoposide/cisplatin as treatment for chemotherapy-naive patients with extensive-disease small-cell lung cancer.
Eckardt JR; von Pawel J; Papai Z; Tomova A; Tzekova V; Crofts TE; Brannon S; Wissel P; Ross G
J Clin Oncol; 2006 May; 24(13):2044-51. PubMed ID: 16648504
[TBL] [Abstract][Full Text] [Related]
39. Cisplatin/etoposide versus carboplatin/etoposide chemotherapy and irradiation in small cell lung cancer: a randomized phase III study. Hellenic Cooperative Oncology Group for Lung Cancer Trials.
Kosmidis PA; Samantas E; Fountzilas G; Pavlidis N; Apostolopoulou F; Skarlos D
Semin Oncol; 1994 Jun; 21(3 Suppl 6):23-30. PubMed ID: 8052870
[TBL] [Abstract][Full Text] [Related]
40. [Treatment of unresectable non-small cell lung cancer (NSCLC) with carboplatin and chronic daily administration of oral etoposide].
Hirabayashi M; Tanaka Y; Yoshida H; Nakagawa M; Kuno K
Gan To Kagaku Ryoho; 1994 Jan; 21(1):53-8. PubMed ID: 8291916
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
